Concepedia

Sajeel Chowdhary

SC

20

Publications

801

Citations

15

H-Index

2002

Active since

Affiliations

Moffitt Cancer Center(Current)

Neurological Surgery

Boca Raton Regional Hospital

University of California, San Francisco

Florida Hospital Cancer Institute

Sajeel Chowdhary is an author at Moffitt Cancer Center specializing in medicine, neuro-oncology, and radiation oncology.

Top concepts

Publications per year

2002–2023

20

Publications

20

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

Kent C. Shih, Sajeel Chowdhary, Paul Rosenblatt et al. · Journal of Neuro-Oncology · 2016 · 122 citations

, , +4

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations

Priscilla K. Brastianos, Erin Twohy, Elizabeth R. Gerstner et al. · Journal of Clinical Oncology · 2022 · 92 citations · Full text

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma

Edward Pan, Daohai Yu, Binglin Yue et al. · Journal of Neuro-Oncology · 2012 · 84 citations · Full text

, , +9

Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma

Prakash Chinnaiyan, Sajeel Chowdhary, Lisa Potthast et al. · Neuro-Oncology · 2011 · 74 citations · Full text

, , +18

Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)

John D. Hainsworth, Kevin Becker, Tarek Mekhail et al. · Journal of Neuro-Oncology · 2019 · 49 citations

, , +10

Rows per page

1–5 of 20